share_log

国药控股(01099.HK)获CITIC Securities Company Limited增持172.52万股普通股股份,价值约3,564.07万港元

Sinopharm (01099.HK) received a shareholding of 1.7252 million shares of common stock from CITIC Securities Company Limited, worth approximately 35.6407 million Hong Kong dollars.

Futu News ·  Nov 29, 2024 17:04

Reported on November 29th, according to the disclosure of the Hong Kong Stock Exchange on November 29th, CITIC Securities Company Limited increased its shareholding on November 27th at an average price of 20.6589 Hong Kong dollars per share.$SINOPHARM (01099.HK)$1.7252 million shares of ordinary shares were purchased, with a value of approximately 35.6407 million Hong Kong dollars. After the increase in shareholding, CITIC Securities Company Limited's latest number of shares held is 81.69 million shares, and the proportion of the warehouse has increased from 5.96% to 6.09%.

HKEXAutoNews_CS20241129E00247.png

What is equity disclosure?

According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.

Why is equity disclosure important?

Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment